Night terrors
Methodology & AI Transparency ⓘ
Night terrors Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Physicians managing Night terrors (F51.4; Insomnia, Sleep Apnea & Sleep Health) utilize 2-week sleep diary/actigraphy [Night terrors F51.4] and objective Apnea-Hypopnea Index (AHI) [Night terrors F51.4] targets (< 5 events/hour (F51.4)) to prevent progression and functional morbidity.
- 2 Real-world patient consensus: Federal ICD-10-CM code F51.4 categorizes Night terrors under Insomnia, Sleep Apnea & Sleep Health.
- 3 Typical cash cost range: Primary evaluation for Night terrors incorporates 2-week sleep diary/actigraphy [Night terrors F51.4] and symptom diary review.
- 4 Top reported side effects / signs: Longitudinal Night terrors monitoring tracks Apnea-Hypopnea Index (AHI) [Night terrors F51.4] toward < 5 events/hour (F51.4).
Ask our AI Specialists anything about Night terrors
What Is Night terrors?
Physicians managing Night terrors (F51.4; Insomnia, Sleep Apnea & Sleep Health) utilize 2-week sleep diary/actigraphy [Night terrors F51.4] and objective Apnea-Hypopnea Index (AHI) [Night terrors F51.4] targets (< 5 events/hour (F51.4)) to prevent progression and functional morbidity.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Night terrors (F51.4) center on or upper-airway pharyngeal in Night terrors (F51.4: collapse during REM). targeted sleep disorders interventions aim to normalize Apnea-Hypopnea Index (AHI) [Night terrors F51.4].
Common Symptoms & Clinical Signs
- • Presentation of Night terrors (F51.4): prolonged sleep-onset latency [Night terrors F51.4]
- • Secondary Night terrors clinical sign: unrefreshing morning waking in Night terrors (F51.4: despite adequate hours)
- • Symptom flares in Night terrors correlating with Apnea-Hypopnea Index (AHI) [Night terrors F51.4] deviation outside < 5 events/hour (F51.4)
- • Functional sleep disorders impact requiring 2-week sleep diary/actigraphy [Night terrors F51.4] evaluation (F51.4)
Night terrors Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F51.4 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Insomnia, Sleep Apnea & Sleep Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Apnea-Hypopnea Index (AHI) [Night terrors F51.4] | < 5 events/hour (F51.4) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Insomnia Severity Index in Night terrors (F51.4: (ISI)) | < 7 (F51.4) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Nocturnal Oxygen Saturation in Night terrors (F51.4: (SpO2)) | >= 94% nadir > 90% (F51.4) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Night terrors
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Night Time Cold and Flu Relief Multi Symptom (Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate) Night Time Cold and Flu Relief Multi Symptom • RxCUI 1094549 | Antihistamine | 90% | $0.0194 | $ 9.90 /mo |
| Original Night-Time Multi-Symptom Cold/Flu Relief (Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate) Original Night-Time Multi-Symptom Cold/Flu Relief • RxCUI 1043400 | Antihistamine | 94% | $0.0194 | $ 9.90 /mo |
| Night Time Severe Cold and Cough Relief (Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl) Night Time Severe Cold and Cough Relief • RxCUI 1298348 | Histamine-1 Receptor Antagonist | 90% | $0.0194 | $ 9.90 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Night terrors)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Check Your Medicine Cabinet: Tonight We Ride, LLC Issues Voluntary Recall of Ultimate Forza Male Supplement Due to Pr Indexed from FDA Drug Recalls (2026-10-24) by DotMD's 2-hour clinical surveillance pipeline. FDA Drug Recalls • 2026-10-24 • FDA Recall | Multi-cohort | 95/100 | PMID FDA_RECALLS-743098658 ↗ |
| New Insights on Obstructive sleep apnoea syndrome and left ventricular: What a 5,550-Participant Study Found The present meta-analysis expands previous information on the relationship between OSA and echocardiographic LVH, so far based on individual studies. Journal of hypertension • 2020-09-15 • Meta-Analysis | N = 5,550 | 94/100 | PMID 32371766 ↗ |
| New Insights on Effect of daridorexant on nighttime wakefulness and next-morning sleepiness:: What a 310-Participant Study Found Daridorexant reduces wakefulness throughout the entire night while independently decreasing morning sleepiness and improving daytime functioning and alertness. Sleep medicine • 2025-07-15 • Phase III Randomized Trial | N = 310 | 93/100 | PMID 40288253 ↗ |
| New Insights on Tadalafil on nighttime voiding (nocturia) in men with lower urinary tract: What a 752-Participant Study Found A statistically significant improvement in nocturnal frequency was seen with tadalafil over placebo; however, the treatment difference was small and not considered clinically meaningful. World journal of urology • 2014-10-15 • Randomized Controlled Trial | N = 752 | 93/100 | PMID 24504761 ↗ |
| New Insights on Aerobic exercise and resistance training on obstructive sleep: What a 526-Participant Study Found Exercise, including resistance and aerobic training, should be part of treatment for patients with obstructive sleep apnea of all severities, regardless of obesity status, and even for those who are already under continuous... Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine • 2024-11-01 • Meta-Analysis | N = 526 | 91/100 | PMID 39150699 ↗ |
Night terrors Patient Community & “People Like Me” Threads
Filter Night terrors community threads and patient logs by age, biological sex, dosage, and treatment duration.